Page last updated: 2024-08-24

tirofiban and Infections, Coronavirus

tirofiban has been researched along with Infections, Coronavirus in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Forleo, GB; Radovanovic, D; Santus, P; Viecca, M1

Trials

1 trial(s) available for tirofiban and Infections, Coronavirus

ArticleYear
Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study.
    Pharmacological research, 2020, Volume: 158

    Topics: Aged; Aspirin; Betacoronavirus; Clopidogrel; Compassionate Use Trials; Coronavirus Infections; COVID-19; Female; Fibrin Fibrinogen Degradation Products; Humans; Hypoxia; Male; Middle Aged; Pandemics; Platelet Aggregation Inhibitors; Pneumonia, Viral; Proof of Concept Study; SARS-CoV-2; Thrombophilia; Tirofiban

2020